HK Stock MarketDetailed Quotes

CSPC PHARMA (01093)

Watchlist
  • 8.230
  • -0.170-2.02%
Trading May 6 11:20 CST
94.83BMarket Cap22.06P/E (TTM)

CSPC PHARMA (01093) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
原料产品-成药20.58B79.15%
原料产品-维生素C2.23B8.59%
功能食品及其他1.82B7.00%
原料产品-抗生素1.57B6.03%
Counterselling-201.38M-0.77%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
原料产品-成药20.58B79.15%
原料产品-维生素C2.23B8.59%
功能食品及其他1.82B7.00%
原料产品-抗生素1.57B6.03%
Counterselling-201.38M-0.77%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China20.83B80.08%
Europe2.43B9.34%
Other Asian regions1.26B4.86%
North America890.21M3.42%
Other596.27M2.29%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More